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Background: polymorphism within regulatory regions of
mmune response genes can affect the level of gene expression.
amma interferon (INF-g) is a cytokine that plays an important role
n immune response to infection of hepatitis B virus (HBV). The aim
f this study is to explore the association between the two single
ucleotide polymorphisms (SNPs) within promoter (at positions -
11G/A,-56T/C) of the gamma interferon receptor1 gene (INFGR1)
nd susceptibility to chronic HBV infection.
Methods: A total of 400 individuals were included in a case-
ontrol study of Iranian populations with chronic HBV infection
nd healthy control group. Genomic DNA from peripheral blood
amples of 200 chronically HBV infected patients and 200 healthy
ontrols were extracted by phenol-chloroform method and geno-
ypingwas performed by PCR-RFLPmethod also p<0.05 considered
s signiﬁcant.
Results: The frequencies of INFGR1 genotypes on -56 position
ere 36/6% for TT and 43/5% for TC and 20% CC in case group and
0.9% TT and 51/7% TC and 27/4% CC for control group(p value:
.002) and frequencies of INFGR1 genotypes on -611 position were
1% forAAand57/5% forAGand1/5%GG incasegroupand37/8%AA
nd 53/7% AG and 8/5% GG for control group (p value: 0.006) . Sig-
iﬁcant difference was observed between case and control group.
Conclusion: A number of single- nucleotide mutations have
een identiﬁed in interferon gamma receptor and its signaling
athway that predispose to chronic HBV infection. There was asso-
iation between INFGR1 polymorphism (promoter at positions
611G/A,-56T/C) and chronic HBV infection. This study suggested
he possibility that INFGR1gene polymorphism beside host genetic
actors can be important in determining an individual’s suscepti-
ility in the progress to chronic HBV infection.
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A conserved matrix epitope based DNA vaccine protects mice
against inﬂuenza A virus challenge
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Background: DNA vaccination represents a unique strategy to
overcome the limitations of immunization with conventional vac-
cineswhich is restricted by the high variability of inﬂuenza viruses.
Theprimeobjectivewas toevaluate theprotectiveefﬁcacyof aplas-
mid DNA (pDNA), encoding an evolutionarily conserved epitope of
viral matrix protein, against the inﬂuenza A virus infection.
Methods: The vaccine construct was generated by cloning the
DNA encoding a nine amino acid long conserved epitope of M1
protein of inﬂuenza A virus in pSecTag2B and its expression was
checked by SDS PAGE andwestern blotting. BALB/cmicewere used
for the ex-vivo study to observe the immune response after inject-
ing the plasmid DNA through intra-muscular route.
Results: It was found that the immunized mice purely elicited
cell mediated immune response to the pDNA, with signiﬁcantly
enhanced level of Th1 cytokines (IL-12 and gamma interferon) pro-
duction in the stimulated splenocyte supernatant. The cytotoxic T
lymphocytes in the spleen of immunized mice signiﬁcantly lysed
the virus infected MDCK cells. A signiﬁcant decrease in virus repli-
cation was also observed in the lungs of immunized mice and 83%
of themicewere protected against the lethal challenge of inﬂuenza
A viruses.
Conclusion: Therefore, the vaccine based on minimal DNA con-
structs encoding the conservedviral epitope seems promising to
provide efﬁcient protection against the inﬂuenza A virus infection
and resulted in broadened immune responses Further engineering
of the plasmid DNA to encode more than one epitope of different
viral proteins may result in better activation of immune response
to provide cross-protection against the emerging viral strains.
http://dx.doi.org/10.1016/j.ijid.2012.05.208
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Clinical risk factors of severity and molecular epidemiology
of respiratory syncytial virus circulating in Kuala Lumpur,
Malaysia: a retrospective study of 21 years
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Background: Respiratory syncytial virus (RSV) is themost com-
mon respiratory virusdetected in children. RSVdisease ranges from
